We are live on
!
Find out more
EVLO
Evelo Biosciences, Inc. Common Stock
EVLO
EVLO
Delisted
EVLO was delisted on the 11th of December, 2023.
38 hedge funds and large institutions have $258M invested in Evelo Biosciences, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
13% more capital invested
Capital invested by funds: $229M → $258M (+$28.9M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 41 → 38 (-3)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Holders
38
Holders Change
-3
Holders Change %
-7.32%
% of All Funds
0.83%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
1
Increased
19
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$189K |
| 2 |
Jane Street
New York
|
-$146K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$55K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$37.7K |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$18K |
